BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences - ECPv5.9.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences
X-ORIGINAL-URL:https://siat-sz.edu.cn
X-WR-CALDESC:Events for Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:2025-12-12 15:25:560101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20251212T072556
DTEND;TZID=UTC:DTSTAMP:20260504T003552Z
CREATED:20251126T152556Z
LAST-MODIFIED:20251209T094212Z
UID:1F2EB5F3-587C-46D6-826B-D785BF95A062@www.xaqj
SUMMARY:倒计时开启！产/学/研/资/医五维交锋：中国CNS最强声音齐聚湾有引力
DESCRIPTION:全球超30亿人，正深陷中枢神经系统（CNS）疾病的困境。CNS药物研发，历来是医药界公认的“硬仗”：平均8-10年征程，成功率仅约6%，远低于行业平均水平。然而，转机已至！跨国药企正强势回归CNS赛道，强生、百时美施贵宝、武田等通过重磅收购布局前沿疗法；礼来Donanemab、革命性精神分裂药物KarXT接连获批，绿叶制药等加速全球布局；更令人振奋的是，中国力量正在这一蓝海强势崛起！2025年，国内CNS领域融资超110亿元，中国在全...
URL:https://www.szbl.ac.cn/info/1017/9705.htm
LOCATION:
ATTACH;FMTTYPE=image/jpeg:https://www.szbl.ac.cnnull
END:VEVENT
END:VCALENDAR